Project Grant DP2AI184830
Award Date
8/15/24
Completion Date
7/31/29
Dollars Obligated
$492K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94143, USA
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $649,053 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to The Washington University in St. Louis to investigate the role of Ly49 receptors on CD8 T cells and their function in regulatory T cell (Treg) development and activity. The research project aims to better understand the determinants of Ly49+ CD8 Treg function, which may inform future approaches to harnessing these cells for treating...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $227,018 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of California, Irvine (UC Irvine). The grant, titled "Microglial Immunity in Toxoplasmic Encephalitis," aims to determine the role of microglia, brain-resident immune cells, in immune defense against Toxoplasma gondii infection, a leading opportunistic pathogen in AIDS patients. The research will...
The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a $737,502 Project Grant to The Washington University in St. Louis. The 5-year grant, effective May 1, 2025, will support research to investigate the role of the WDFY4 protein in the activation and development of regulatory T cells (Tregs), which are essential for maintaining immune tolerance. The research aims to: 1) determine the impact of WDFY4...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,653,244 Project Grant (R01AI186111) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Regents of the University of California, doing business as the University of California, Berkeley (UC Berkeley). The project aims to engineer improved vaccine adjuvants through iterative microbial production and systems immunology research. Specifically, the grant will fund efforts to redesign the...
This federal Project Grant award in the amount of $995,244.00 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The primary objective of this research project is to determine whether genetic mutations that alter the transcriptional activity of the BHLH transcription factor ASCL1 contribute to the development of organ-specific autoimmunity in humans. The research is being conducted by the...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,030,400 Project Grant (R21AI182967) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Scripps Research Institute in La Jolla, California. The grant supports a mechanistic investigation into the role of the FBXW7 ubiquitin ligase in regulating the NLRP3 inflammasome, a key mediator of inflammatory responses involved in infectious diseases and chronic conditions. The research aims to...
The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a $192,788 Project Grant (R21AI180901) to the University of California, San Diego (UCSD) to identify regulators of plasmacytoid dendritic cell (pDC) function and exhaustion. The award aims to conduct a genome-wide CRISPR screening to discover novel factors that control IFN-I production and pDC exhaustion, which is critical for antiviral defense...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $8,276,078 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Regents of the University of California, San Francisco (UCSF) on July 12, 2024. The grant funds a 5-center randomized controlled trial to evaluate preemptive therapy (PET) versus antiviral prophylaxis (AP) for preventing cytomegalovirus (CMV) disease in 360 CMV donor-positive/recipient-negative kidney transplant...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $800,005 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to The General Hospital Corporation (Massachusetts General Hospital) to investigate the structural basis and functional mechanisms of G-protein coupled receptor (GPCR) variants associated with autoimmune diseases. The key objectives include: Defining the structural basis for impaired function of the autoimmunity-associated GPR65 variant and...
The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a $693,465 Project Grant to Cornell University to conduct research on mapping infant and adult T cell immunity. The project aims to construct a molecular atlas of T cell development in lymph nodes and determine how cellular interactions and communication networks change during CD8+ T cell priming throughout childhood. The research will investigate...